
According to a September 19th report by PR Newswire, Charlotte's Web, a leading company in the CBD industry, has become a founding member of ONE HEMP. ONE HEMP is an alliance comprised of top stakeholders in the CBD industry, aiming to support Congress and the U.S. Food and Drug Administration (FDA) in achieving rational regulation of dietary supplements through scientific and data-supported approaches.
As leaders in the CBD market, which is based on cannabis, we prioritize science, safety, and responsible business practices. We stand united with ONE HEMP in bringing clarity and stability to the market. The CBD industry and Congress should have taken action long ago," said Jared Stanley, co-founder and COO of Charlotte's Web. "It has been a decade since cannabis-based CBD became a healthy choice for over 45 million daily CBD consumers in the US. Over these ten years, rigorous scientific research, innovation, safety and toxicology studies, current good manufacturing practices, label standards, and valuable consumer feedback have all demonstrated the self-regulation implemented by responsible CBD suppliers to build a new industry.
Charlotte's Web Holdings, Inc. is a B-grade certified company headquartered in Louisville, Colorado. It is a market leader in innovative cannabis extract health products, with brands such as Charlotte's Web™, ReCreate™, CBD Medic™, and CBD Clinic™. Charlotte's Web offers full-spectrum and broad-spectrum options for their plant-based CBD extract, including ReCreate™ by Charlotte's Web and NSF for Sport certified broad-spectrum CBD®.
ONE HEMP's founding mission is to urge Congress and the FDA to establish regulatory standards that classify CBD products as dietary supplements and serve as a leading scientific resource for policymakers to ensure consumer safety and consistency. ONE HEMP is an industry working group composed of leading voices and CBD market leaders. The group has recruited some of the world's foremost cannabinoid researchers and toxicologists to ensure their approaches are firmly rooted in reliable scientific research and a deep understanding of CBD's safety profile. ONE HEMP aims to set industry benchmarks and foster trust and innovation in the CBD field.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.